U

Ultimovacs ASA
OSE:ULTI

Watchlist Manager
Ultimovacs ASA
OSE:ULTI
Watchlist
Price: 14.5 NOK 0.69% Market Closed
Market Cap: 293.3m NOK

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of ULTI.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ULTI Intrinsic Value
Not Available
U
Base Case Scenario
Compare ULTI to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about ULTI?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Ultimovacs ASA

Current Assets 113.8m
Cash & Short-Term Investments 111.4m
Receivables 379k
Other Current Assets 2.1m
Non-Current Assets 2m
PP&E 2m
Current Liabilities 31.5m
Accounts Payable 4.8m
Other Current Liabilities 26.7m
Non-Current Liabilities 1.7m
Long-Term Debt 230k
Other Non-Current Liabilities 1.5m
Efficiency

Free Cash Flow Analysis
Ultimovacs ASA

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Ultimovacs ASA

Revenue
0 NOK
Operating Expenses
-151.3m NOK
Operating Income
-151.3m NOK
Other Expenses
-49.8m NOK
Net Income
-201.1m NOK
Fundamental Scores

ULTI Profitability Score
Profitability Due Diligence

Ultimovacs ASA's profitability score is 21/100. The higher the profitability score, the more profitable the company is.

Low 3Y Average Gross Margin
Low 3Y Average Net Margin
Low 3Y Average Operating Margin
Declining ROE
21/100
Profitability
Score

Ultimovacs ASA's profitability score is 21/100. The higher the profitability score, the more profitable the company is.

ULTI Solvency Score
Solvency Due Diligence

Ultimovacs ASA's solvency score is 53/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Low D/E
Short-Term Solvency
Long-Term Solvency
53/100
Solvency
Score

Ultimovacs ASA's solvency score is 53/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ULTI Price Targets Summary
Ultimovacs ASA

There are no price targets for ULTI.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Ultimovacs ASA
does not pay dividends
Shareholder Yield

Current shareholder yield for ULTI is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y